More than 15 years ago, Olopade and Wei[28] described a model of ovarian cancer tumor progression that implicated aberrant FANCF promoter methylation and correlated with gene silencing and disruption of the Fanconi-anemia-BRCA pathway. This evidence concerns the gene FANCF and Fanconi anemia.